Profile data is unavailable for this security.
About the company
Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
- Revenue in DKK (TTM)--
- Net income in DKK--
- Incorporated2000
- Employees10.58k
- LocationNovozymes A/SKrogshoejvej 36BAGSVAERD 2880DenmarkDNK
- Phone+45 44460000
- Fax+45 44469999
- Websitehttps://www.novozymes.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ems Chemie Holding AG | 16.43bn | 3.79bn | 122.64bn | 2.76k | 32.38 | 7.22 | 28.81 | 7.46 | 19.75 | 19.75 | 85.69 | 88.60 | 0.8193 | -- | 5.92 | 709,534.40 | 19.08 | 22.10 | 21.80 | 26.30 | -- | 44.96 | 23.29 | 22.82 | 4.52 | -- | 0.0117 | 87.59 | -5.40 | -0.7734 | 0.7015 | -2.65 | -12.19 | -4.12 |
| Novozymes A/S | -100.00bn | -100.00bn | 165.85bn | 10.58k | -- | 2.32 | -- | -- | -- | -- | -- | 172.31 | -- | -- | -- | -- | -- | 8.89 | -- | 10.95 | -- | 53.00 | -- | 16.11 | 1.00 | -- | 0.2244 | 50.56 | 59.53 | 14.76 | -24.68 | -6.26 | 21.92 | 3.41 |
| Sika AG | 93.69bn | 9.79bn | 205.66bn | 34.56k | 24.23 | -- | 14.32 | 2.20 | 6.45 | 6.45 | 53.40 | -- | -- | -- | -- | 331,427.70 | -- | 8.93 | -- | 11.09 | 54.73 | 52.80 | 10.47 | 10.56 | -- | 12.16 | -- | 35.32 | 4.67 | 7.72 | 17.28 | 10.62 | 13.30 | 9.37 |
| Givaudan SA | 61.26bn | 8.78bn | 233.10bn | 17.58k | 26.67 | 6.26 | 19.74 | 3.80 | 115.47 | 115.47 | 805.52 | 491.59 | 0.6236 | 2.96 | 4.54 | 425,028.40 | 8.94 | 8.24 | 11.42 | 10.25 | 43.52 | 42.10 | 14.33 | 13.29 | 1.13 | 41.48 | 0.4915 | 66.94 | 0.8095 | 3.40 | -1.74 | 7.59 | 6.09 | 2.38 |
Data as of Feb 13 2026. Currency figures normalised to Novozymes A/S's reporting currency: Danish Krone DKK
16.51%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 07 Jan 2026 | 13.02m | 3.14% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 11.12m | 2.68% |
| Pictet Asset Management SAas of 08 Jan 2026 | 7.94m | 1.92% |
| BlackRock Fund Advisorsas of 09 Jan 2026 | 5.97m | 1.44% |
| Impax Asset Management Ltd.as of 31 Dec 2025 | 5.60m | 1.35% |
| Fidelity Management & Research Co. LLCas of 31 Dec 2025 | 5.60m | 1.35% |
| APG Asset Management NVas of 31 Dec 2024 | 5.55m | 1.34% |
| Comgest SAas of 28 Nov 2025 | 5.30m | 1.28% |
| BlackRock Investment Management (UK) Ltd.as of 06 Feb 2026 | 4.35m | 1.05% |
| Geode Capital Management LLCas of 05 Feb 2026 | 3.97m | 0.96% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
